FR2336133A1 - Derives trifluoromethylthio (et sulfonyle) d'analogues de cyproheptadine utiles comme medicaments - Google Patents

Derives trifluoromethylthio (et sulfonyle) d'analogues de cyproheptadine utiles comme medicaments

Info

Publication number
FR2336133A1
FR2336133A1 FR7637940A FR7637940A FR2336133A1 FR 2336133 A1 FR2336133 A1 FR 2336133A1 FR 7637940 A FR7637940 A FR 7637940A FR 7637940 A FR7637940 A FR 7637940A FR 2336133 A1 FR2336133 A1 FR 2336133A1
Authority
FR
France
Prior art keywords
cyproheptadine
trifluoromethylthio
sulfonyl
derivatives
medicinal products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7637940A
Other languages
English (en)
Other versions
FR2336133B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of FR2336133A1 publication Critical patent/FR2336133A1/fr
Application granted granted Critical
Publication of FR2336133B1 publication Critical patent/FR2336133B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic Table
    • C07F3/02Magnesium compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7637940A 1975-12-22 1976-12-16 Derives trifluoromethylthio (et sulfonyle) d'analogues de cyproheptadine utiles comme medicaments Granted FR2336133A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,863 US4031222A (en) 1975-12-22 1975-12-22 Trifluoromethylthio (and sulfonyl) derivatives of cyproheptadine analogs

Publications (2)

Publication Number Publication Date
FR2336133A1 true FR2336133A1 (fr) 1977-07-22
FR2336133B1 FR2336133B1 (fr) 1978-11-17

Family

ID=24578354

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7637940A Granted FR2336133A1 (fr) 1975-12-22 1976-12-16 Derives trifluoromethylthio (et sulfonyle) d'analogues de cyproheptadine utiles comme medicaments

Country Status (26)

Country Link
US (1) US4031222A (fr)
JP (1) JPS5278880A (fr)
AT (1) AT363936B (fr)
AU (1) AU506996B2 (fr)
BE (1) BE849678A (fr)
CA (1) CA1085823A (fr)
CH (7) CH625790A5 (fr)
DE (1) DE2657978C3 (fr)
DK (1) DK550976A (fr)
ES (6) ES454468A1 (fr)
FI (1) FI763545A (fr)
FR (1) FR2336133A1 (fr)
GB (1) GB1519080A (fr)
GR (1) GR62010B (fr)
HU (1) HU175018B (fr)
IE (1) IE44362B1 (fr)
IL (1) IL51103A (fr)
LU (1) LU76382A1 (fr)
NL (1) NL7613713A (fr)
NO (1) NO146359C (fr)
NZ (1) NZ182868A (fr)
PH (1) PH14088A (fr)
PL (4) PL116941B1 (fr)
PT (1) PT65956B (fr)
SE (1) SE7613796L (fr)
ZA (1) ZA767579B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148903A (en) * 1977-07-28 1979-04-10 Merck & Co., Inc. Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines
US4132796A (en) * 1977-12-01 1979-01-02 Merck & Co., Inc. Antipsychotic 3-trifluoromethylsulfinyl analogs of cyproheptadine
US4285956A (en) * 1978-05-12 1981-08-25 Kefalas A/S Xanthene and thioxanthene derivatives, compositions thereof and treatment therewith
US4195091A (en) * 1978-11-15 1980-03-25 Merck & Co., Inc. Appetite stimulating pyrrolo[2,1-b][3]benzazepines
EP0012988B1 (fr) * 1979-01-02 1983-04-27 Merck & Co. Inc. Enantiomères lévogyres et dextrogyres de 3-halocyproheptadines, procédé pour leur préparation et composition pharmaceutique les contenant
US4275070A (en) * 1979-05-21 1981-06-23 Merck & Co., Inc. Antipsychotic pharmaceutical compositions of the levorotatory enantiomers of 3-methoxycyproheptadine and an analog thereof
US4220651A (en) * 1979-05-21 1980-09-02 Merck & Co., Inc. Antipsychotic levorotatory enantiomers of 3-halocyproheptadines, analogs and derivatives
EP0019797A1 (fr) * 1979-05-21 1980-12-10 Merck & Co. Inc. Enantiomères lévogyres et dextrogyres de 3-méthoxycyproheptadine et leurs analogues, procédé pour leur préparation et compositions pharmaceutiques à activité antipsychotique
US5231105A (en) * 1987-06-02 1993-07-27 Ajinomoto Co., Inc. Ethylamine derivatives and antihypertensives containing the same
US5393890A (en) 1988-06-02 1995-02-28 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
US4996321A (en) * 1990-02-26 1991-02-26 Merck & Co., Inc. Dibenzo[a,d]cycloheptenylidene compounds
US5021426A (en) * 1990-02-26 1991-06-04 Merck & Co., Inc. Method of traeting malaria with cyproheptadine derivatives
CN103130708B (zh) * 2011-12-01 2016-08-10 上海药明康德新药开发有限公司 一种n-叔丁氧羰基-4-硝基哌啶的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3851059A (en) * 1970-02-05 1974-11-26 Merck & Co Inc Method for the stimulation of appetite in patients

Also Published As

Publication number Publication date
NO146359C (no) 1982-09-15
ES466549A1 (es) 1978-10-01
AT363936B (de) 1981-09-10
ATA943376A (de) 1981-02-15
CH626344A5 (fr) 1981-11-13
IL51103A (en) 1980-11-30
DE2657978B2 (de) 1980-06-04
HU175018B (hu) 1980-04-28
CA1085823A (fr) 1980-09-16
PH14088A (en) 1981-02-10
IL51103A0 (en) 1977-02-28
PT65956B (en) 1978-11-07
US4031222A (en) 1977-06-21
PL116947B1 (en) 1981-07-31
ES466553A1 (es) 1978-10-01
PL116346B1 (en) 1981-06-30
FR2336133B1 (fr) 1978-11-17
ES466551A1 (es) 1978-10-01
BE849678A (fr) 1977-06-21
CH631164A5 (de) 1982-07-30
GR62010B (en) 1979-02-15
IE44362L (en) 1977-06-22
AU506996B2 (en) 1980-01-31
CH626345A5 (fr) 1981-11-13
ES466550A1 (es) 1978-10-01
NZ182868A (en) 1979-03-28
PT65956A (en) 1977-01-01
IE44362B1 (en) 1981-11-04
NL7613713A (nl) 1977-06-24
GB1519080A (en) 1978-07-26
NO146359B (no) 1982-06-07
CH627167A5 (fr) 1981-12-31
ES454468A1 (es) 1978-04-16
PL122145B1 (en) 1982-06-30
NO764188L (fr) 1977-06-23
PL116941B1 (en) 1981-07-31
CH625790A5 (fr) 1981-10-15
CH626343A5 (fr) 1981-11-13
LU76382A1 (fr) 1977-06-28
CH626346A5 (fr) 1981-11-13
AU2052876A (en) 1978-06-22
JPS5278880A (en) 1977-07-02
ZA767579B (en) 1978-08-30
DK550976A (da) 1977-06-23
PL194577A1 (fr) 1980-01-28
DE2657978C3 (de) 1981-02-12
FI763545A (fr) 1977-06-23
ES466552A1 (es) 1978-10-01
DE2657978A1 (de) 1977-06-23
SE7613796L (sv) 1977-06-23

Similar Documents

Publication Publication Date Title
FR2360587B1 (fr) Nouveaux derives d'amino-alcoyl-furannes utiles comme medicaments
PT86819A (pt) Process for the preparation of novel insulin derivatives and of pharmaceutical compositions containing the same
FR2336133A1 (fr) Derives trifluoromethylthio (et sulfonyle) d'analogues de cyproheptadine utiles comme medicaments
JPS5328178A (en) Production of novel pyperidylindole derivatives * salt thereof and pharmaceutical composition
IL52280A0 (en) New derivatives of penicillanic acid their preparation and pharmaceutical compositions containing them
IL58080A0 (en) Acid addition salts of 16 -monoquaternary ammonium derivatives of 2 ,16 -bis-piperidino-and rostanes and pharmaceutical compositions containing them
JPS5271459A (en) Production of novel fusidic acid derivatives and compounding pharmaceutical agent
BE870531A (fr) Analogues de la prostaglandine e1 et compositions pharmaceutiques les contenant
LU79356A1 (fr) Preparation d'interphenylene 8-aza-9-dioxathia-11,12-secoprostaglandines utiles comme medicaments
IL52858A0 (en) New derivatives of perhydro-aza-heterocycles their production and pharmaceutical compositions containing them
GR63213B (en) 4-trifluormethylbenzoic acid derivatives and process of making the same and pharmaceutical compositions containing thereof
IL52996A0 (en) New derivatives of 2-(3-phenyl-2-aminopropionyloxy) acetic acid their preparation and pharmaceutical compositions containing them
IL52717A0 (en) Novel derivatives of 2-phenylamino-imidazoline-(2), their preparation and pharmaceutical compositions containing them
IL54859A (en) Derivatives of amidinopenicillanic acid,their production and pharmaceutical compositions containing them
PT87202A (pt) Process for the preparation of novel acyl derivatives and of pharmaceutical compositions containing the same
FR2321294A1 (fr) Derives d'acides 7b-amino-3-cephem-3-carbonylmethyl-4-carboxyliques utiles comme medicaments
PH13924A (en) Glavulanic acid derivatives,pharmaceutical compositions containing same and method of preparation thereof
IL51426A0 (en) Novel derivatives of tetrahydroechinocandin b their production and pharmaceutical compositions containing them
NZ184408A (en) 16-s-acyl derivatives of 16-deacetoxy-fusidic acid and pharmaceutical compositions
PT87679A (pt) A process for the preparation of 2-methoxymethyl-penem derivatives and of pharmaceutical compositions containing the same
ZA784501B (en) Derivatives of n-substituted-2-aminobenzoic acid,processesfor their preparation and pharmaceutical compositions thereof
FR2336134A1 (fr) Derives trifluoromethylthio de cyproheptadine utiles comme medicament
JPS52136156A (en) Production of novel 177 spirosultine derivatives and corresponding gammaa hydroxylic acid and pharmaceutical composition
FR2313937A1 (fr) Medicament a base de 5' thioethers de l'adenosine
BE859084A (fr) Nouveaux derives de l'imidazo (5,1-a)isoquinoleine, leur preparation et leur application comme medicaments

Legal Events

Date Code Title Description
ST Notification of lapse